Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Prognostication of Molecular Relapses after Dasatinib or Nilotinib Discontinuation in Chronic Myeloid Leukemia (CML): A FI-LMC STOP 2G-TKI Study Update

Delphine Rea, MD, Franck E Nicolini, MDPhD, Michel Tulliez, MD, Philippe Rousselot, MDPhD, Martine Gardembas, MD, Gabriel Etienne, MD PhD, Francois Guilhot, MD, Joelle Guilhot, PhD, Agnès Guerci, MD PhD, Martine Escoffre-Barbe, MD, Laurence Legros, MD PhD, Bruno Villemagne, MD, Gaëlle Guillerm, MD, Marie-Pierre Noel, MD, Valerie Coiteux, MD, Jean-Michel Pignon, MD, Francois-Xavier Mahon, MD PhD

Blood (2019) 134 (Supplement_1): 30.

https://doi.org/10.1182/blood-2019-124408

Published: 2019

Journal Articles

Efficacy of Mitoxantrone-Based Salvage Therapies in Relapsed or Refractory Acute Myeloid Leukemia in the Mayo Clinic Cancer Center: Analysis of Survival after CLAG-M Vs. MEC

Caleb J Scheckel, DO, Megan Meyer, MD, Lanyu Mi, MS, James L. Slack, MD, Pierre Noel, MD, Jose F. Leis, MD PhD, Lisa Z. Sproat, James M. Foran, MD, Aref Al-Kali, MD, Rhett P. Ketterling, William J. Hogan, MB, BCh, Mark R. Litzow, MD, Jeanne Palmer, MD

Blood (2018) 132 (Supplement 1): 2678.

https://doi.org/10.1182/blood-2018-99-114655

Published: 2018

Journal Articles

Does Early T Cell Chimerism Predict Outcomes after Allogeneic Hematopoietic Cell Transplantation ?

Tania Jain, MD, Luke Mountjoy, DO, Katie L. Kunze, PhD, Pierre Noel, MD, Nandita Khera, MD, Jose F. Leis, MD PhD, James L. Slack, MD, Lisa Z. Sproat, Jeanne Palmer, MD

Blood (2018) 132 (Supplement 1): 3360.

https://doi.org/10.1182/blood-2018-99-115287

Published: 2018

Journal Articles

Clinical Outcomes of Matched Unrelated Allogeneic Stem Cell Transplant Patients: Low Dose ATG Vs. No ATG

Luke Mountjoy, DO, Katie L. Kunze, PhD, Tania Jain, MD, James L. Slack, MD, Nandita Khera, MD, Jose F. Leis, MD PhD, Pierre Noel, MD, Lisa Z. Sproat, Jeanne Palmer, MD

Blood (2018) 132 (Supplement 1): 5715.

https://doi.org/10.1182/blood-2018-99-112217

Published: 2018

Journal Articles

Pre-Transplantation Predictors of Survival in Patients Undergoing Allogeneic Stem Cell Transplant for Myelofibrosis

Jeanne Palmer, MD, Tania Jain, MD, Katie L. Kunze, PhD, Daniel K. Partain, MD, Nandita Khera, MD, Lisa Sproat, MD MSW, Pierre Noel, MD, James L. Slack, MD, Vivek Roy, MD, Jose F. Leis, MD PhD, William J. Hogan, MBBCh, Ayalew Tefferi, MD, Veena D. S. Fauble, MD, Mrinal M. Patnaik, MDMBBS, Heidi Elizabeth Kosiorek, MS, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 4598.

https://doi.org/10.1182/blood.V130.Suppl_1.4598.4598

Published: 2017

Journal Articles

Transfusion Dependence at Day +100 Predicts Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation for Myelofibrosis

Tania Jain, MD, Katie L. Kunze, PhD, Daniel K. Partain, MD, Heidi Kosiorek, MS, Vivek Roy, MD, Nandita Khera, MD, James L. Slack, MD, Mrinal M. Patnaik, MDMBBS, William J. Hogan, MBBCh, Pierre Noel, MD, Veena D. S. Fauble, MD, Jose F. Leis, MD PhD, Lisa Sproat, MD MSW, Ruben A Mesa, MD, Jeanne Palmer, MD

Blood (2017) 130 (Supplement 1): 4561.

https://doi.org/10.1182/blood.V130.Suppl_1.4561.4561

Published: 2017

Journal Articles

A Single Center Analysis of Clofarabine Use Prior to Bone Marrow Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Caleb J Scheckel, DO, Jeffrey Alan Betcher, BSPharm, RPh, Lisa Sproat, MD MSW, Nandita Khera, MD, James L. Slack, MD, Jose F. Leis, MD PhD, Pierre Noel, MD, Raoul Tibes, Lanyu Mi, MS, Jeanne Palmer, MD

Blood (2017) 130 (Supplement 1): 5057.

https://doi.org/10.1182/blood.V130.Suppl_1.5057.5057

Published: 2017

Journal Articles

Comparison of Mitoxantrone-Based Salvage Therapies (MEC vs CLAG-M) in Relapsed or Refractory Acute Myeloid Leukemia

Caleb J Scheckel, DO, Jeffrey Alan Betcher, BSPharm, RPh, Lisa Sproat, MD MSW, Raoul Tibes, James L. Slack, MD, Jose F. Leis, MD PhD, Pierre Noel, MD, Lanyu Mi, MS, Jeanne Palmer, MD

Blood (2017) 130 (Supplement 1): 5058.

https://doi.org/10.1182/blood.V130.Suppl_1.5058.5058

Published: 2017

Journal Articles

Evaluation of Revised International Staging System for Transplant-Eligible Multiple Myeloma Patients

Veronica Gonzalez-Calle, MD, Abigail Slack, Susan Luft, M.S., R.N., Kathryn Pearce, Rhett P. Ketterling, MD, Tania Jain, M.B., B.S, Sinto Sebastian Chirackal, PhD, Craig B. Reeder, MD, Joseph Mikhael, MD, Leif Bergsagel, MD, Pierre Noel, MD, Angela Mayo, P.A.-C., M.S., James L. Slack, MD, Roberta H. Adams, MD, Gregory Ahmann, Esteban Braggio, PhD, Keith Stewart, M.B., Ch.B., Scott Van Wier, Rafael Fonseca, MD

Blood (2016) 128 (22): 3452.

https://doi.org/10.1182/blood.V128.22.3452.3452

Published: 2016

Journal Articles

Treatment with Bortezomib (Bor) Based Therapy Followed By Autologous Stem Cell Transplantation (SCT) Improves Outcomes in Light Chain Amyloidosis (AL)

Tania Jain, M.B.,B.S, Shu Ting Kung, MD, Vishal Shah, Pharm.D., R.Ph., Amylou Constance Dueck, PhD, Heidi E. Kosiorek, MS, Joseph Mikhael, MD, P. Leif Bergsagel, MD, Craig B. Reeder, MD, Pierre Noel, MD, Roberta H. Adams, MD, Susan Luft, M.S., R.N., Angela Mayo, P.A.-C., M.S., A. Keith Stewart, M.B., Ch.B., Rafael Fonseca, MD

Blood (2016) 128 (22): 4629.

https://doi.org/10.1182/blood.V128.22.4629.4629

Published: 2016

Journal Articles

Day +30 and Day +100 CD33 Chimerisms Predict Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis

Tania Jain, M.B.,B.S, M'hamed Temkit, Daniel K. Partain, MD, Mrinal M Patnaik, MBBS, James L. Slack, MD, Nandita Khera, MD, William J. Hogan, MBChB, Vivek Roy, MD, Pierre Noel, MD, Jose F Leis, MD PhD, Lisa Sproat, MD MSW, Veena DS Fauble, MD, Ruben A. Mesa, MD, Jeanne Palmer, MD

Blood (2016) 128 (22): 4653.

https://doi.org/10.1182/blood.V128.22.4653.4653

Published: 2016

Journal Articles

Safety Profile of Bortezomib Impacts Survival in Light Chain Amyloidosis

Zoé Van de Wyngaert, MD, Greg Vanoutryve, Guillemette Fouquet, MD, Stéphanie Guidez, Charles Herbaux, MD, Helene Demarquette, MD, Loic Renaud, Louis Terriou, MD, Marie Pierre Noel, MD, Marie Odile Petillon, MD, Bénédicte Hivert, MD, Matthieu Wemeau, MD, David Launay, MDPhD, Nicolas Lamblin, MD, Eric Hachulla, MD PhD, Thierry Facon, MD, Xavier Leleu, MD

Blood (2014) 124 (21): 5664.

https://doi.org/10.1182/blood.V124.21.5664.5664

Published: 2014

Journal Articles

Rituximab For Hairy-Cell Leukemia (HCL): A Multicentric Retrospective Study Of 41 Cases

Mathieu Leclerc, MD, Felipe Suarez, MD, PhD, Marie-Pierre Noël, MD, Anne Vekhoff, MD, Xavier Troussard, MD, Jean-François Claisse, MD, Catherine Thieblemont, MD, PhD, Frédéric Maloisel, MD, PhD, Yves Beguin, MD, PhD, Jérôme Tamburini, MD, PhD, Coralie Barbe, MD, Alain Delmer, MD

Blood (2013) 122 (21): 5308.

https://doi.org/10.1182/blood.V122.21.5308.5308

Published: 2013

Journal Articles

Short Course Infliximab and Extracorporeal Photopheresis As Therapy For Steroid-Refractory Acute Gvhd In Matched Related and Unrelated Allogeneic Hematopoietic Cell Transplant (HCT)

Jared Klein, MD, James L Slack, MD, Lisa Sproat, MD, MSW, Veena Fauble, MD, Nandita Khera, MD, MPH, Jose F. Leis, MD, PhD, Pierre Noel, MD, Sergio Torloni, MD, Roberta H. Adams, MD, Jeff Betcher, RPh

Blood (2013) 122 (21): 4590.

https://doi.org/10.1182/blood.V122.21.4590.4590

Published: 2013

Journal Articles

Does Allogeneic Hematopoietic Cell Transplantation Benefit Older (≥ 60) AML/MDS Patients With Monosomal Karyotype?

James L Slack, MD, Nandita Khera, MD, MPH, Veena Fauble, MD, Jose F Leis, MD, PhD, Lisa Sproat, MD, MSW, Jared Klein, MD, Craig B. Reeder, MD, Jeffrey A Betcher, R.Ph., Pierre Noel, MD

Blood (2013) 122 (21): 3399.

https://doi.org/10.1182/blood.V122.21.3399.3399

Published: 2013

Journal Articles

Reduced Toxicity Conditioning With Fludarabine, BCNU, Melphalan and Anti-Thymocyte Globulin Followed By Allogeneic Stem Cell Transplant For Patients With Primary and Post ET/PV Myelofibrosis: Single Center Experience At Mayo Clinic Arizona

Blood (2013) 122 (21): 2835.

https://doi.org/10.1182/blood.V122.21.2835.2835

Published: 2013

Journal Articles

Impact Of Vitamin D Level Pre and Post Allogeneic Hematopoietic Stem Cell Transplant

Kristen Beebe, PA-C, Jane Olsen, NP, Yu-hui Chang, PhD, Mary Burkhart, NP, Lori DeCook, PA-C, Susan Gerber, PA-C, Kimberley Settineri, PA-C, Jane Palmer, NP, Joanne Schlesinger, NP, Roberta Adams, MD, Veena Fauble, MD, Nandita Khera, MD, MPH, Jared Klein, MD, Jose Leis, MD, PhD, Pierre Noel, MD, Meagan Higgins, NP, Craig Reeder, MD, James L Slack, MD, Lisa Sproat, MD, MSW

Blood (2013) 122 (21): 4616.

https://doi.org/10.1182/blood.V122.21.4616.4616

Published: 2013

Journal Articles

A Phase 2 Study Of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) For Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy: Waldenström’s Macroglobulinemia Cohort Results

Blood (2013) 122 (21): 4352.

https://doi.org/10.1182/blood.V122.21.4352.4352

Published: 2013

Journal Articles

Financial Burden In Recipients Of Allogeneic Hematopoietic Cell Transplantation

Nandita Khera, MD, MPH, Yu-hui Chang, PhD, Shahrukh K Hashmi, MD, James L Slack, MD, Veena Fauble, MD, Timothy Beebe, PhD, Vivek Roy, M.D., Lisa Sproat, MD, MSW, Jose F. Leis, MD, PhD, Pierre Noel, MD, Jon Tilburt, MD, Joseph R. Mikhael, MD

Blood (2013) 122 (21): 721.

https://doi.org/10.1182/blood.V122.21.721.721

Published: 2013

Journal Articles

Preliminary Report Of The STIM2 Study: A Multicenter Stop Imatinib Trial For Chronic Phase Chronic Myeloid Leukemia De Novo Patients On Imatinib

Francois-Xavier Mahon, MD, PhD, Franck E. Nicolini, MD, PhD, Marie-Pierre Noël, MD, Martine Escoffre, MD, Aude Charbonnier, MD, Delphine Rea, MD, PhD, Viviane Dubruille, Bruno R. Varet, MD, Laurence Legros, MD, PhD, Agnès Guerci, MD, Gabriel Etienne, MD, PHD, Francois Guilhot, MD, Stéphanie Dulucq, PharmD, Philippe Rousselot, MD, PhD, Joelle Guilhot, PhD

Blood (2013) 122 (21): 654.

https://doi.org/10.1182/blood.V122.21.654.654

Published: 2013

NARROW

Prognostication of Molecular Relapses after Dasatinib or Nilotinib Discontinuation in Chronic Myeloid Leukemia (CML): A FI-LMC STOP 2G-TKI Study Update

Efficacy of Mitoxantrone-Based Salvage Therapies in Relapsed or Refractory Acute Myeloid Leukemia in the Mayo Clinic Cancer Center: Analysis of Survival after CLAG-M Vs. MEC

Does Early T Cell Chimerism Predict Outcomes after Allogeneic Hematopoietic Cell Transplantation ?

Clinical Outcomes of Matched Unrelated Allogeneic Stem Cell Transplant Patients: Low Dose ATG Vs. No ATG

Pre-Transplantation Predictors of Survival in Patients Undergoing Allogeneic Stem Cell Transplant for Myelofibrosis

Transfusion Dependence at Day +100 Predicts Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation for Myelofibrosis

A Single Center Analysis of Clofarabine Use Prior to Bone Marrow Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Comparison of Mitoxantrone-Based Salvage Therapies (MEC vs CLAG-M) in Relapsed or Refractory Acute Myeloid Leukemia

Evaluation of Revised International Staging System for Transplant-Eligible Multiple Myeloma Patients

Treatment with Bortezomib (Bor) Based Therapy Followed By Autologous Stem Cell Transplantation (SCT) Improves Outcomes in Light Chain Amyloidosis (AL)

Day +30 and Day +100 CD33 Chimerisms Predict Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis

Safety Profile of Bortezomib Impacts Survival in Light Chain Amyloidosis

Rituximab For Hairy-Cell Leukemia (HCL): A Multicentric Retrospective Study Of 41 Cases

Short Course Infliximab and Extracorporeal Photopheresis As Therapy For Steroid-Refractory Acute Gvhd In Matched Related and Unrelated Allogeneic Hematopoietic Cell Transplant (HCT)

Does Allogeneic Hematopoietic Cell Transplantation Benefit Older (≥ 60) AML/MDS Patients With Monosomal Karyotype?

Reduced Toxicity Conditioning With Fludarabine, BCNU, Melphalan and Anti-Thymocyte Globulin Followed By Allogeneic Stem Cell Transplant For Patients With Primary and Post ET/PV Myelofibrosis: Single Center Experience At Mayo Clinic Arizona

Impact Of Vitamin D Level Pre and Post Allogeneic Hematopoietic Stem Cell Transplant

A Phase 2 Study Of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) For Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy: Waldenström’s Macroglobulinemia Cohort Results

Financial Burden In Recipients Of Allogeneic Hematopoietic Cell Transplantation

Preliminary Report Of The STIM2 Study: A Multicenter Stop Imatinib Trial For Chronic Phase Chronic Myeloid Leukemia De Novo Patients On Imatinib

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only